Prognostic and predictive value of tumor vascular endothelial growth factor gene amplification in metastatic breast cancer treated with paclitaxel with and without bevacizumab; results from ECOG 2100 trial (Q30537414)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Prognostic and predictive value of tumor vascular endothelial growth factor gene amplification in metastatic breast cancer treated with paclitaxel with and without bevacizumab; results from ECOG 2100 trial |
scientific article |
Statements
1 reference
Prognostic and predictive value of tumor vascular endothelial growth factor gene amplification in metastatic breast cancer treated with paclitaxel with and without bevacizumab; results from ECOG 2100 trial (English)
1 reference
Sunil S Badve
1 reference
Gail Vance
1 reference
Kathy D Miller
1 reference
Edith A Perez
1 reference
George W Sledge
1 reference
Bryan P Schneider
1 reference
Guanglong Jiang
1 reference
Milan Radovich
1 reference
Fei Shen
1 reference
Joseph A Sparano
1 reference
Robert J Gray
1 reference
Lang Li
1 reference
Julie R Gralow
1 reference
Maura N Dickler
1 reference
Melody A Cobleigh
1 reference
Tamara N Shenkier
1 reference
Kirsten Vang Nielsen
1 reference
Sven Müller
1 reference
Ann Thor
1 reference
Nancy E Davidson
1 reference
22 January 2013
1 reference
1 reference
1281-1289
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference